ArticleOncoimmunology2024

Peptide-guided adaptor-CAR T-Cell therapy for the treatment of SSTR2-expressing neuroendocrine tumors.

Christian Pellegrino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.